Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Monolong

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ANI Pharma Launches FDA-Approved Isosorbide Tablets
    ANI Pharma Launches FDA-Approved Isosorbide Tablets

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3269952/0/en/ANI-Pharmaceuticals-Announces-FDA-Approval-and-Launch-of-Isosorbide-Mononitrate-Tablet.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain
    Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain

    16 Feb 2024

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-lifesciences-gets-usfda-nod-for-generic-drug-to-prevent-chest-pain-in-heart-patients/articleshow/107750842.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    16 Feb 2024
    Share Share
    Aurobindo's Generic Isosorbide Mononitrate Receives Approval in the U.S.
    Aurobindo's Generic Isosorbide Mononitrate Receives Approval in the U.S.

    07 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216557

    FDA
    07 Nov 2022
    Share Share
    Substitution instrument to address shortage of isosorbide mononitrate
    Substitution instrument to address shortage of isosorbide mononitrate

    17 Sep 2021

    // TGA

    https://www.tga.gov.au/alert/substitution-instrument-address-shortage-imdur-durules-and-monodur-durules-isosorbide-mononitrate-120-mg-modified-release-tablets

    TGA
    17 Sep 2021
    Share Share
    Riconpharma 's Generic Isosorbide Mononitrate Receives Approval in US
    Riconpharma 's Generic Isosorbide Mononitrate Receives Approval in US

    08 Nov 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210918

    FDA
    08 Nov 2018
    Share Share
    Dexcel's Generic Isosorbide Mononitrate Receives Approval in US
    Dexcel's Generic Isosorbide Mononitrate Receives Approval in US

    01 Sep 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210822

    FDA
    01 Sep 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.